Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Clinical and Experimental Immunology
|
June 1, 1979
Pulmonary function changes in normal rats induced by antibody against rat IgE
F B Casey, B E Abboa-Offei
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1980
Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo
F B Casey, B E Abboa-Offei, J Marretta
Journal of Cardiovascular Pharmacology
|
September 1, 1996
Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors
A A Seymour, P D Mathers, B E Abboa-Offei, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1992
Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats
A A Seymour, M M Asaad, B E Abboa-Offei, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1996
Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors
A A Seymour, M M Asaad, B E Abboa-Offei, et al.
Journal of Cardiovascular Pharmacology
|
November 1, 1996
In vivo pharmacology of dual neutral endopeptidase/angiotensin-converting enzyme inhibitors
A A Seymour, M M Asaad, B E Abboa-Offei, et al.
Clinical and Experimental Pharmacology & Physiology
|
January 1, 1995
Potentiation of natriuretic peptides by neutral endopeptidase inhibitors
A A Seymour, B E Abboa-Offei, P L Smith, et al.
Journal of Cardiovascular Pharmacology
|
November 1, 1996
Renal and depressor activities of inhibitors of neutral endopeptidase and angiotensin converting enzyme in monkeys infused with angiotensin II
A A Seymour, M M Asaad, B E Abboa-Offei, et al.
Journal of Medicinal Chemistry
|
May 23, 1997
Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase
J A Robl, C Q Sun, J Stevenson, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2007
Arylpropanolamines: selective beta3 agonists arising from strategies to mitigate phase I metabolic transformations
W N Washburn, T W Harper, G Wu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Clinical and Experimental Immunology
|
June 1, 1979
Pulmonary function changes in normal rats induced by antibody against rat IgE
F B Casey, B E Abboa-Offei
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1980
Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo
F B Casey, B E Abboa-Offei, J Marretta
Journal of Cardiovascular Pharmacology
|
September 1, 1996
Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors
A A Seymour, P D Mathers, B E Abboa-Offei, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1992
Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats
A A Seymour, M M Asaad, B E Abboa-Offei, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1996
Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors
A A Seymour, M M Asaad, B E Abboa-Offei, et al.
Journal of Cardiovascular Pharmacology
|
November 1, 1996
In vivo pharmacology of dual neutral endopeptidase/angiotensin-converting enzyme inhibitors
A A Seymour, M M Asaad, B E Abboa-Offei, et al.
Clinical and Experimental Pharmacology & Physiology
|
January 1, 1995
Potentiation of natriuretic peptides by neutral endopeptidase inhibitors
A A Seymour, B E Abboa-Offei, P L Smith, et al.
Journal of Cardiovascular Pharmacology
|
November 1, 1996
Renal and depressor activities of inhibitors of neutral endopeptidase and angiotensin converting enzyme in monkeys infused with angiotensin II
A A Seymour, M M Asaad, B E Abboa-Offei, et al.
Journal of Medicinal Chemistry
|
May 23, 1997
Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase
J A Robl, C Q Sun, J Stevenson, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2007
Arylpropanolamines: selective beta3 agonists arising from strategies to mitigate phase I metabolic transformations
W N Washburn, T W Harper, G Wu, et al.
Page
of 2